We are live on ! Find out more
GI

GAMMA Investing Portfolio holdings

AUM $2.69B
1-Year Est. Return 42.78%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+42.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.17B
AUM Growth
+$164M
Cap. Flow
+$157M
Cap. Flow %
13.37%
Top 10 Hldgs %
25.72%
Holding
3,876
New
301
Increased
2,412
Reduced
769
Closed
99

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$7.19M
2
NVDA icon
NVIDIA
NVDA
+$5.82M
3
MSFT icon
Microsoft
MSFT
+$5.63M
4
AMZN icon
Amazon
AMZN
+$4.37M
5
TSLA icon
Tesla
TSLA
+$3.01M

Sector Composition

Rank Sector Weight
1 Technology 24.89%
2 Financials 12.52%
3 Consumer Discretionary 8.81%
4 Healthcare 7.95%
5 Industrials 7.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVGW
2076
DELISTED
Calavo Growers
CVGW
$16K ﹤0.01%
629
+24
+4% +$653
EPC icon
2077
Edgewell Personal Care
EPC
$1.29B
$16K ﹤0.01%
476
+75
+19% +$2.65K
MLAB icon
2078
Mesa Laboratories
MLAB
$569M
$16K ﹤0.01%
121
-2
-2% -$246
COTY icon
2079
Coty
COTY
$2.51B
$16K ﹤0.01%
2,292
+1,779
+347% +$13.7K
ARQT icon
2080
Arcutis Biotherapeutics
ARQT
$3.26B
$15.9K ﹤0.01%
1,140
+83
+8% +$909
VRNT
2081
DELISTED
Verint Systems
VRNT
$15.8K ﹤0.01%
574
+20
+4% +$500
MDGL icon
2082
Madrigal Pharmaceuticals
MDGL
$11.9B
$15.7K ﹤0.01%
51
+25
+96% +$7.03K
EPD icon
2083
Enterprise Products Partners
EPD
$82B
$15.7K ﹤0.01%
500
SRCE icon
2084
1st Source
SRCE
$2.1B
$15.6K ﹤0.01%
268
+60
+29% +$3.71K
OWL icon
2085
Blue Owl Capital
OWL
$18.2B
$15.6K ﹤0.01%
672
+213
+46% +$4.88K
OI icon
2086
O-I Glass
OI
$1.08B
$15.6K ﹤0.01%
1,441
-961
-40% -$11.7K
ZD icon
2087
Ziff Davis
ZD
$2B
$15.6K ﹤0.01%
287
+205
+250% +$10.8K
ALV icon
2088
Autoliv
ALV
$8.92B
$15.6K ﹤0.01%
166
+15
+10% +$1.44K
NTB icon
2089
Bank of N.T. Butterfield & Son
NTB
$2.46B
$15.5K ﹤0.01%
425
+203
+91% +$7.6K
ALT icon
2090
Altimmune
ALT
$593M
$15.5K ﹤0.01%
2,147
-220
-9% -$1.68K
BWB icon
2091
Bridgewater Bancshares
BWB
$598M
$15.5K ﹤0.01%
1,145
-11
-1% -$162
EBS icon
2092
Emergent Biosolutions
EBS
$229M
$15.4K ﹤0.01%
1,614
-96
-6% -$881
REPX icon
2093
Riley Exploration Permian
REPX
$802M
$15.3K ﹤0.01%
480
+172
+56% +$5.3K
FL
2094
DELISTED
Foot Locker
FL
$15.3K ﹤0.01%
704
+344
+96% +$8.04K
PAR icon
2095
PAR Technology
PAR
$753M
$15.3K ﹤0.01%
210
+70
+50% +$4.79K
HUN icon
2096
Huntsman Corp
HUN
$1.82B
$15.3K ﹤0.01%
846
+406
+92% +$8.46K
UTZ icon
2097
Utz Brands
UTZ
$1.25B
$15.2K ﹤0.01%
973
+324
+50% +$5.48K
LGF.A
2098
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$15.2K ﹤0.01%
1,784
+766
+75% +$6.04K
FA icon
2099
First Advantage
FA
$4.05B
$15.2K ﹤0.01%
812
-47
-5% -$892
IRON icon
2100
Disc Medicine
IRON
$3.01B
$15.2K ﹤0.01%
239
+139
+139% +$8.04K

Similar funds

GAMMA Investing's Q4 2024 Portfolio in Review

As of Q4 2024, GAMMA Investing held 3,876 positions worth $1.17B, up 16% from $1.01B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

GAMMA Investing deployed $157M of net new capital in Q4 2024, opening 301 new positions and adding to 2,412 existing holdings. Its largest new stake was iShares China Large-Cap ETF: 7,320 shares worth $223K.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $1.01M trimmed.

  • GAMMA Investing's largest Q4 2024 buy was iShares China Large-Cap ETF: 7,320 shares worth $223K.
  • GAMMA Investing added most to Apple in Q4 2024, an estimated $7.19M increase.
  • GAMMA Investing's biggest Q4 2024 reduction was Johnson & Johnson, cutting an estimated $1.01M.
  • GAMMA Investing fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $634K.
  • GAMMA Investing's ten largest holdings make up 26% of its $1.17B portfolio in Q4 2024.
  • GAMMA Investing opened 301 new positions and closed 99 in Q4 2024.
  • GAMMA Investing's portfolio value rose 16% quarter-over-quarter to $1.17B.

Based on GAMMA Investing's 13F filing for Q4 2024, filed 3 Jan 2025.